DJIA 16,351.38 293.03 1.82%
NASDAQ 4,749.98 113.87 2.46%
S&P 500 1,948.86 35.01 1.83%
market minute promo

AbbVie Inc. (NYSE: ABBV)

60.98 0.48 (0.79%)

Quote as of


company name or ticker

Recent Quotes

ABBV $60.98 0.79%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $61.56
Previous Close $60.50
Daily Range $60.28 - $61.60
52-Week Range $52.06 - $71.60
Market Cap $100.9B
P/E Ratio 47.27
Dividend (Yield) $2.04 (3.4%)
Ex-Dividend Date
Dividend Pay Date
07/13/15
08/14/15
Volume 12,031,729
Average Daily Volume 10,061,765
Current FY EPS $4.26

Sector

Industry

AbbVie Inc. (ABBV) Description

AbbVie Inc. Website: http://www.abbvie.com/

News & Commentary

A $25 Billion Hedge Fund Just Made AbbVie One of Its Biggest Bets

AbbVie Inc. could end up sidestepping lost sales tied to an expiring patent on Humira in 2017.

Bristol-Myers/AbbVie Cancer Drug Gets Priority Review

U.S. Food and Drug Administration Accepts for Priority Review the Biologics License Application for

U.S. Food and Drug Administration Accepts for Priority Review the Biologics License Application for Empliciti (elotuzumab) for the Treatment of Multiple Myeloma in Patients Who Have Received One or More Prior Therapies

After Hours Most Active for Aug 31, 2015 : TV, MSFT, QQQ, ABBV, GE, INTC, EXEL, FTR, T, PFE, FB, F

After Hours Most Active for Aug 31, 2015 : TV, MSFT, QQQ, ABBV, GE, INTC, EXEL, FTR, T, PFE, FB, F

Amgen Poised To Dominate A $32 Billion Biosimilar Market

CELG, PFE, REGN, RCPT Jim Cramer's Views

On Babies And Bathwater

November Options Are Low Risk Way To Play Neurocrine Biosciences' Pending Catalysts

Premarket Biotech Digest: CLL Treatment, Gilead CEO Sells, Acelity IPO

Comments On The Market Correction; Focus On Biotechs: Large Caps

Premarket Biotech Digest: Major Mayo Research, Axovant Still Shortable, Mylan Perrigo Bid

See More ABBV News...